(Q52620425)

4 May 2018

title

Smad3 mediates ANG II-induced hypertensive kidney disease in mice. (English)

1 reference

4 May 2018

1 reference

Zhen Liu

1

1 reference

4 May 2018

Xiao R Huang

series ordinal

2

1 reference

4 May 2018

Hui Y Lan

series ordinal

3

1 reference

4 May 2018

publication date

11 January 2012

1 reference

4 May 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

4 May 2018

volume

302

1 reference

4 May 2018

issue

8

1 reference

4 May 2018

page(s)

F986-97

1 reference

4 May 2018

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Hypertensive nephropathy: prevention and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Diverse roles of TGF-β/Smads in renal fibrosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Smad7 as a therapeutic agent for chronic kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

NF-kappaB in renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Essential role of Smad3 in angiotensin II-induced vascular fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00595.2011

10.1152/AJPRENAL.00595.2011

21 January 2018

Identifiers

DOI

1 reference

4 May 2018

1 reference

4 May 2018